Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
In brief
The primary objective of this study is to compare the efficacy of tarlatamab with placebo as assessed by progression free survival (PFS) based on blinded independent central review (BCIR) per response evaluation criteria in solid tumors v1.1 (RECIST 1.1) and on prolonging overall survival (OS).
Key facts
- Study ID
- NCT06117774
- Run by
- Amgen
- People needed
- 404
- Starts
- 2024-02-20
- Expected to finish
- 2030-04-20
- Last updated by the study team
- 2026-04-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California Los Angeles — Santa Monica, California, United States
- Yale New Haven Hospital — New Haven, Connecticut, United States
- Boca Raton Clinical Research Global South Florida — Plantation, Florida, United States
- University of Louisville James Graham Brown Cancer Center — Louisville, Kentucky, United States
- Our Lady of the Lake Cancer Institute — Baton Rouge, Louisiana, United States
- Morristown Medical Center — Morristown, New Jersey, United States
- New York University Grossman School of Medicine and New York University Langone Hospitals — New York, New York, United States
- Perlmutter Cancer Center at New York University Langone Hospital - Long Island — New York, New York, United States
- Montefiore Einstein Center for Cancer Care — The Bronx, New York, United States
- FirstHealth Cancer Center — Pinehurst, North Carolina, United States
- Lehigh Valley Health Network — Allentown, Pennsylvania, United States
- Spokenword Clinical Trials — Easton, Pennsylvania, United States
- Renovatio Clinical — The Woodlands, Texas, United States
- US Oncology Research Investigational Products Center — The Woodlands, Texas, United States
- University of Virginia Health System — Charlottesville, Virginia, United States
- Virginia Cancer Specialists, PC — Fairfax, Virginia, United States
- West Virginia University Health Sciences Center — Morgantown, West Virginia, United States
- Fundacion Respirar — Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Hospital Italiano de La Plata — La Plata, Buenos Aires, Argentina
- Hospital Universitario Austral — Pilar, Buenos Aires, Argentina
- Instituto Oncologico de Cordoba Ionc Fundacion Richardet Longo — Córdoba, Córdoba Province, Argentina
- Hospital Aleman Buenos Aires — CABA, Distrito Federal, Argentina
- Clinica Viedma — Viedma, Río Negro Province, Argentina
- Sanatorio 9 de Julio Cice 9 de Julio — San Miguel de Tucumán, Tucumán Province, Argentina
- Valkyrie Clinical Trials — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.